PAR paradigm biopharmaceuticals limited..

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-40

  1. 1,510 Posts.
    lightbulb Created with Sketch. 186
    First deal will set the benchmark for other deals later on so make a tonne of sense for them to get the best one possible, and drag out the process a bit. No doubt that they can get a deal (if it is to satisfy some here worried about non-commercialisation) but the quality of the deal matters more long term.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.0¢
Change
0.030(10.3%)
Mkt cap ! $124.6M
Open High Low Value Volume
29.0¢ 33.5¢ 29.0¢ $669.4K 2.105M

Buyers (Bids)

No. Vol. Price($)
7 104399 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 6303 2
View Market Depth
Last trade - 15.40pm 24/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.